Caas Capital Management LP Boston Scientific Corp Put Options Transaction History

Caas Capital Management LP

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Oct 28, 2024	BUY	$72.96 - $84.0 $7,295 - $8,400	100 Added 3.7%	2,800 $234,000
Q2 2024 Jul 15, 2024	SELL	$67.33 - $77.71 $74,063 - $85,481	-1,100 Reduced 28.95%	2,700 $207,000
Q1 2024 Apr 26, 2024	SELL	$57.6 - $68.62 $17,280 - $20,586	-300 Reduced 7.32%	3,800 $260,000
Q4 2023 Feb 14, 2024	BUY	$48.64 - $57.81 $199,424 - $237,021	4,100 New	4,100 $237,000
Q1 2023 May 15, 2023	BUY	$45.09 - $50.03 $144,288 - $160,096	3,200 New	3,200 $160,000
Q4 2020 Feb 12, 2021	BUY	$33.15 - $41.97 $1.99 Million - $2.52 Million	60,000 New	60,000 $2.16 Million

1,542

1.19B

6.79M

10.1M

Ticker BSX
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,431,609,984
Market Cap $130B
Description
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...

Get notified when there are updates to the investment portfolio of Caas Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Caas Capital Management LP with notifications on news.